CT perfusion in evaluation of post therapy cervical lymphoma

Objective: Compare CT perfusion between responders and non-responders in patients with residual cervical nodes after lymphoma treatment. Subjects and methods: Twenty-seven patients with treated pathologically proved lymphoma were included in this prospective study, divided into two groups: responder...

Full description

Bibliographic Details
Main Authors: Nihal M. Batouty, Amina A. Sultan, Nazem A. Shams, Nahed Abd El-Gaber, Mahmoud A. Rashed
Format: Article
Language:English
Published: SpringerOpen 2016-12-01
Series:The Egyptian Journal of Radiology and Nuclear Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0378603X16301164
_version_ 1818503715891445760
author Nihal M. Batouty
Amina A. Sultan
Nazem A. Shams
Nahed Abd El-Gaber
Mahmoud A. Rashed
author_facet Nihal M. Batouty
Amina A. Sultan
Nazem A. Shams
Nahed Abd El-Gaber
Mahmoud A. Rashed
author_sort Nihal M. Batouty
collection DOAJ
description Objective: Compare CT perfusion between responders and non-responders in patients with residual cervical nodes after lymphoma treatment. Subjects and methods: Twenty-seven patients with treated pathologically proved lymphoma were included in this prospective study, divided into two groups: responders (n. 15) and non-responders to treatment (n. 12). Blood flow (BF), blood volume (BV), mean transit time (MTT) and permeability (PS) were determined using CT perfusion. Lymph nodes sizes were measured (short axis). Results: BF, BV and PS were significantly higher in non-responders group [93.3 (65.3–111) ml/min/100 g, 6.3 (5.2–8) ml/100 g and 18.9 (14.5–25.1) ml/min/100 g respectively] as compared to responders group [54 (43.8–77.5) ml/min/100 g, 4.1 (2.2–4.8) ml/100 g and 9.4 (7.5–14.5) ml/min/100 g respectively], [p 0.019, 0.004 and 0.004 respectively]. MTT had a trend to be low in non-responders group, but did not reach statistical significance (p 0.305). Cutoff value for BF, BV and PS was 59.5 ml/min/100 g, 3.6 ml/100 g and 11.1 ml/min/100 g respectively, 92% sensitivity for the three parameters and specificity 67%, 47% and 73% respectively. Lymph node sizes had no relation to the perfusion parameter values. Conclusion: CT perfusion is a functional imaging tool with promising results in differentiating between responders and non-responders in treated lymphoma patients, using BF, BV and PS.
first_indexed 2024-12-10T21:27:41Z
format Article
id doaj.art-7294f33235574c0191bce02f6fee12b7
institution Directory Open Access Journal
issn 0378-603X
language English
last_indexed 2024-12-10T21:27:41Z
publishDate 2016-12-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Radiology and Nuclear Medicine
spelling doaj.art-7294f33235574c0191bce02f6fee12b72022-12-22T01:32:57ZengSpringerOpenThe Egyptian Journal of Radiology and Nuclear Medicine0378-603X2016-12-014741673167910.1016/j.ejrnm.2016.07.012CT perfusion in evaluation of post therapy cervical lymphomaNihal M. BatoutyAmina A. SultanNazem A. ShamsNahed Abd El-GaberMahmoud A. RashedObjective: Compare CT perfusion between responders and non-responders in patients with residual cervical nodes after lymphoma treatment. Subjects and methods: Twenty-seven patients with treated pathologically proved lymphoma were included in this prospective study, divided into two groups: responders (n. 15) and non-responders to treatment (n. 12). Blood flow (BF), blood volume (BV), mean transit time (MTT) and permeability (PS) were determined using CT perfusion. Lymph nodes sizes were measured (short axis). Results: BF, BV and PS were significantly higher in non-responders group [93.3 (65.3–111) ml/min/100 g, 6.3 (5.2–8) ml/100 g and 18.9 (14.5–25.1) ml/min/100 g respectively] as compared to responders group [54 (43.8–77.5) ml/min/100 g, 4.1 (2.2–4.8) ml/100 g and 9.4 (7.5–14.5) ml/min/100 g respectively], [p 0.019, 0.004 and 0.004 respectively]. MTT had a trend to be low in non-responders group, but did not reach statistical significance (p 0.305). Cutoff value for BF, BV and PS was 59.5 ml/min/100 g, 3.6 ml/100 g and 11.1 ml/min/100 g respectively, 92% sensitivity for the three parameters and specificity 67%, 47% and 73% respectively. Lymph node sizes had no relation to the perfusion parameter values. Conclusion: CT perfusion is a functional imaging tool with promising results in differentiating between responders and non-responders in treated lymphoma patients, using BF, BV and PS.http://www.sciencedirect.com/science/article/pii/S0378603X16301164CT perfusionLymphomaCervical lymphadenopathy
spellingShingle Nihal M. Batouty
Amina A. Sultan
Nazem A. Shams
Nahed Abd El-Gaber
Mahmoud A. Rashed
CT perfusion in evaluation of post therapy cervical lymphoma
The Egyptian Journal of Radiology and Nuclear Medicine
CT perfusion
Lymphoma
Cervical lymphadenopathy
title CT perfusion in evaluation of post therapy cervical lymphoma
title_full CT perfusion in evaluation of post therapy cervical lymphoma
title_fullStr CT perfusion in evaluation of post therapy cervical lymphoma
title_full_unstemmed CT perfusion in evaluation of post therapy cervical lymphoma
title_short CT perfusion in evaluation of post therapy cervical lymphoma
title_sort ct perfusion in evaluation of post therapy cervical lymphoma
topic CT perfusion
Lymphoma
Cervical lymphadenopathy
url http://www.sciencedirect.com/science/article/pii/S0378603X16301164
work_keys_str_mv AT nihalmbatouty ctperfusioninevaluationofposttherapycervicallymphoma
AT aminaasultan ctperfusioninevaluationofposttherapycervicallymphoma
AT nazemashams ctperfusioninevaluationofposttherapycervicallymphoma
AT nahedabdelgaber ctperfusioninevaluationofposttherapycervicallymphoma
AT mahmoudarashed ctperfusioninevaluationofposttherapycervicallymphoma